1. Home
  2. EXEL vs PCTY Comparison

EXEL vs PCTY Comparison

Compare EXEL & PCTY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • EXEL
  • PCTY
  • Stock Information
  • Founded
  • EXEL 1994
  • PCTY 1997
  • Country
  • EXEL United States
  • PCTY United States
  • Employees
  • EXEL N/A
  • PCTY N/A
  • Industry
  • EXEL Biotechnology: Biological Products (No Diagnostic Substances)
  • PCTY Computer Software: Prepackaged Software
  • Sector
  • EXEL Health Care
  • PCTY Technology
  • Exchange
  • EXEL Nasdaq
  • PCTY Nasdaq
  • Market Cap
  • EXEL 9.8B
  • PCTY 10.4B
  • IPO Year
  • EXEL 2000
  • PCTY 2014
  • Fundamental
  • Price
  • EXEL $43.04
  • PCTY $190.90
  • Analyst Decision
  • EXEL Buy
  • PCTY Strong Buy
  • Analyst Count
  • EXEL 18
  • PCTY 19
  • Target Price
  • EXEL $38.76
  • PCTY $223.21
  • AVG Volume (30 Days)
  • EXEL 3.9M
  • PCTY 402.1K
  • Earning Date
  • EXEL 05-13-2025
  • PCTY 07-31-2025
  • Dividend Yield
  • EXEL N/A
  • PCTY N/A
  • EPS Growth
  • EXEL 237.58
  • PCTY 16.86
  • EPS
  • EXEL 2.20
  • PCTY 4.01
  • Revenue
  • EXEL $2,298,922,000.00
  • PCTY $1,551,771,000.00
  • Revenue This Year
  • EXEL $10.39
  • PCTY $14.87
  • Revenue Next Year
  • EXEL $10.74
  • PCTY $9.37
  • P/E Ratio
  • EXEL $19.53
  • PCTY $47.62
  • Revenue Growth
  • EXEL 24.49
  • PCTY 14.63
  • 52 Week Low
  • EXEL $20.40
  • PCTY $129.94
  • 52 Week High
  • EXEL $48.85
  • PCTY $223.80
  • Technical
  • Relative Strength Index (RSI)
  • EXEL 59.93
  • PCTY 45.90
  • Support Level
  • EXEL $42.21
  • PCTY $193.37
  • Resistance Level
  • EXEL $43.75
  • PCTY $197.92
  • Average True Range (ATR)
  • EXEL 1.60
  • PCTY 3.52
  • MACD
  • EXEL -0.09
  • PCTY -1.04
  • Stochastic Oscillator
  • EXEL 53.96
  • PCTY 23.71

About EXEL Exelixis Inc.

Exelixis Inc is a biopharmaceutical firm that discovers, develops, and commercializes treatments for cancer. Its molecule, cabozantinib, is indicated for the treatment of patients with metastatic medullary thyroid cancer under the name Cometriq and for the treatment of kidney and liver cancer under the name Cabometyx. Exelixis and its partner Roche have also brought Cotellic to market for the treatment of melanoma.

About PCTY Paylocity Holding Corporation

Paylocity is a provider of payroll and human capital management solutions servicing small- to midsize clients in the United States. The company was founded in 1997 and targets businesses with 10-5,000 employees and services about 39,000 clients as of fiscal 2024. Alongside core payroll services, Paylocity offers HCM solutions such as time and attendance and recruiting software as well as workplace collaboration and communication tools.

Share on Social Networks: